甲状腺髓样癌的自然史为高级疾病管理提供信息
利用甲状腺髓样癌的自然史为高级疾病管理提供信息
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
研究概览
地位
条件
详细说明
PRIMARY OBJECTIVES:
I. To describe the natural history of medullary thyroid cancer (MTC) using a comprehensive battery of demographic, clinical, pathologic, and genotypic variables collected in our existing multi-institutional patient registry.
Ia. To describe the demographic, clinical, pathologic, and genotypic variables associated with each phase of disease.
Ib. To identify those variables which are predictors of progression to the most advanced phases of disease that require small molecule therapy, including commercially approved and experimental agents.
II. To characterize patients' experience with the different phases of MTC through a systematic evaluation of patient-reported outcomes (PROs).
IIa. To describe clinical, psychosocial, economic, and physical well-being variables and the subsequent impact on quality of life associated with each phase of disease.
IIb. To evaluate longitudinal changes in clinical, psychosocial, economic, and physical well-being variables between and within all phases of MTC, and the subsequent impact they have on quality of life.
III. To evaluate the association of selected biometric and patient-reported outcomes on adherence, change, and discontinuation of approved targeted therapies and drugs being tested within clinical trial.
OUTLINE:
AIM I & II: Patients complete questionnaires over 10-40 minutes 2-4 times per year about health and how finances and quality of life effect experience with disease.
AIM III: Patients complete a questionnaire over 2 minutes and undergo blood pressure measurements every day for up to 12 weeks.
The questionnaire data gets paired with the collected medical record history that is maintained in the Registry.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Elizabeth G Grubbs
- 电话号码:713-792-6940
- 邮箱:eggrubbs@mdanderson.org
学习地点
-
-
California
-
San Francisco、California、美国、94143
- 招聘中
- University of California San Francisco
-
接触:
- Julie A. Sosa
- 电话号码:415-476-1236
-
首席研究员:
- Julie A. Sosa
-
-
Texas
-
Houston、Texas、美国、77030
- 招聘中
- M D Anderson Cancer Center
-
接触:
- Elizabeth G. Grubbs
- 电话号码:713-792-6940
- 邮箱:eggrubbs@mdanderson.org
-
首席研究员:
- Elizabeth G. Grubbs
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients diagnosed with MTC including advanced phase MTC determined by clinical team
描述
Inclusion Criteria:
- Aims 1 and 2: A diagnosis of MTC
- Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment
- Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team
- Aim 3: A current registrant in the MTCR
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Observational (questionnaire, blood pressure)
AIM I & II: Patients complete questionnaires over 10-40 minutes 2-4 times per year about health and how finances and quality of life effect experience with disease. AIM III: Patients complete a questionnaire over 2 minutes and undergo blood pressure measurements every day for up to 12 weeks. |
Complete questionnaires Undergo blood pressure measurement |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Natural history of medullary thyroid cancer (MTC)
大体时间:Up to 4 years
|
Will describe the natural history of MTC using comprehensive battery of demographic, clinical, pathologic, and genotypic variables collected in existing multi-institutional patient registry. |
Up to 4 years
|
|
Patients' experience with the different phases of MTC
大体时间:Up to 4 years
|
Will characterize patients' experience with the different phases of MTC through a systematic evaluation of patient-reported outcomes (PROs). |
Up to 4 years
|
|
Association of selected biometric and patient-reported outcomes
大体时间:Up to 4 years
|
Will evaluate the association of selected biometric and patient-reported outcomes on adherence, change, and discontinuation of approved targeted therapies and drugs being tested within clinical trial. |
Up to 4 years
|
合作者和调查者
调查人员
- 首席研究员:Elizabeth G Grubbs、M.D. Anderson Cancer Center
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.